View on Pubmed.gov 26598495 | View on doi.org 10.1093/brain/a...
Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
- 1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
- 1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 3 Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA 4 Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA sontheimer@vt.edu eroberson@uab.edu.
- 1 Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA 2 Center for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham, AL, USA sontheimer@vt.edu eroberson@uab.edu.
Abstract
Reduced cerebral blood flow impairs cognitive function and ultimately causes irreparable damage to brain tissue. The gliovascular unit, composed of neural and vascular cells, assures sufficient blood supply to active brain regions. Astrocytes, vascular smooth muscle cells, and pericytes are important players within the gliovascular unit modulating vessel diameters. While the importance of the gliovascular unit and the signals involved in regulating local blood flow to match neuronal activity is now well recognized, surprisingly little is known about this interface in disease. Alzheimer's disease is associated with reduced cerebral blood flow. Here, we studied how the gliovascular unit is affected in a mouse model of Alzheimer's disease, using a combination of ex vivo and in vivo imaging approaches. We specifically labelled vascular amyloid in living mice using the dye methoxy-XO4. We elicited vessel responses ex vivo using either pharmacological stimuli or cell-specific calcium uncaging in vascular smooth muscle cells or astrocytes. Multi-photon in vivo imaging through a cranial window allowed us to complement our ex vivo data in the presence of blood flow after label-free optical activation of vascular smooth muscle cells in the intact brain. We found that vascular amyloid deposits separated astrocyte end-feet from the endothelial vessel wall. High-resolution 3D images demonstrated that vascular amyloid developed in ring-like structures around the vessel circumference, essentially forming a rigid cast. Where vascular amyloid was present, stimulation of astrocytes or vascular smooth muscle cells via ex vivo Ca(2+) uncaging or in vivo optical activation produced only poor vascular responses. Strikingly, vessel segments that were unaffected by vascular amyloid responded to the same extent as vessels from age-matched control animals. We conclude that while astrocytes can still release vasoactive substances, vascular amyloid deposits render blood vessels rigid and reduce the dynamic range of affected vessel segments. These results demonstrate a mechanism that could account in part for the reduction in cerebral blood flow in patients with Alzheimer's disease.media-1vid110.1093/brain/awv327_video_abstractawv327_video_abstract.
References
Ann N Y Acad Sci. 2007 Feb;1097:40-50
PLoS Biol. 2004 Apr;2(4):E96
Acta Neuropathol. 2009 Jul;118(1):87-102
Nat Neurosci. 2006 Feb;9(2):260-7
Cited by 123 citations (total)
Journal Article Review
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.
Electronic publication date May 21, 2016
Anna Chiarini [...] Ilaria Dal Prà et al.
In aged subjects, late-onset Alzheimer's disease (LOAD) starts in the lateral entorhinal allocortex where a failure of clearance mechanisms triggers...
Journal Article
Parallels between retinal and brain pathology and response to immunotherapy in old, late-stage Alzheimer's disease mouse models.
Electronic publication date October 23, 2020
Jonah Doustar [...] Maya Koronyo-Hamaoui et al.
Despite growing evidence for the characteristic signs of Alzheimer's disease (AD) in the neurosensory retina, our understanding of retina-brain relationships,...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
Substances
Copyright
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.